We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
Role of inflammatory markers in brain ischemia.
Current Opinion in Neurology 2008 June
PURPOSE OF REVIEW: Inflammatory mechanisms play an important role in the risk of stroke and during the acute phase of brain ischemia, which contributes to functional outcome of patients. We review the role of inflammatory markers in these aspects of brain ischemia.
RECENT FINDINGS: Systemic inflammatory mechanisms are associated with higher risk of stroke and vascular recurrences after a first ischemic stroke. Several inflammatory molecules are implicated during the acute phase of ischemic stroke, such as cytokines (interleukin-6, tumor necrosis factor-alpha), adhesion cell molecules (vascular cell adhesion molecule type 1, intercellular adhesion molecule type 1) and metalloproteinases. Metalloproteinases and vascular cell adhesion molecule levels are useful in the diagnosis of ischemic stroke. Inflammatory cytokines (interleukin-6 and tumor necrosis factor-alpha) and adhesion cell molecules are related to the presence of early neurological deterioration and infarct volume. Finally, metalloproteinases play an important role in the development of hemorrhagic transformation.
SUMMARY: Molecular markers of inflammation can be useful tools for the management of patients with ischemic stroke, both during the acute phase and to predict prognosis and prevent the risk of a new vascular event.
RECENT FINDINGS: Systemic inflammatory mechanisms are associated with higher risk of stroke and vascular recurrences after a first ischemic stroke. Several inflammatory molecules are implicated during the acute phase of ischemic stroke, such as cytokines (interleukin-6, tumor necrosis factor-alpha), adhesion cell molecules (vascular cell adhesion molecule type 1, intercellular adhesion molecule type 1) and metalloproteinases. Metalloproteinases and vascular cell adhesion molecule levels are useful in the diagnosis of ischemic stroke. Inflammatory cytokines (interleukin-6 and tumor necrosis factor-alpha) and adhesion cell molecules are related to the presence of early neurological deterioration and infarct volume. Finally, metalloproteinases play an important role in the development of hemorrhagic transformation.
SUMMARY: Molecular markers of inflammation can be useful tools for the management of patients with ischemic stroke, both during the acute phase and to predict prognosis and prevent the risk of a new vascular event.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app